Coriolis Pharma invites you to their event

AUC – A real alternative for characterization and QC analysis of biologics, vaccines and gene therapy vectors? (on-demand)

About this event

AUC is a highly versatile analytical method and brings valuable benefits during the research and development of (bio)pharmaceutical drug products.

AUC is based on a simple principle: when (macro)molecules in solution are subject to a centrifugal force, they begin to settle at a certain velocity. With a mathematical correlation between sedimentation behavior and hydrodynamic properties, scientists can determine many critical parameters of a drug substance or drug product for a variety of biopharmaceutical applications, from analyzing small peptides to investigating macromolecular interactions.

In this webinar we will talk about AUC as an alternative to traditional methods for the characterization and QC analysis. The application for biologics, vaccines, as well as gene and cell therapy products, will be taken particularly into account.


LEARNING OBJECTIVES

  • What is the principle of AUC?
  • Which questions can be answered by AUC during characterization of biologics (e.g. protein & peptides), vaccines and gene therapy vectors?
  • Why moving AUC towards QC testing?

Hosted by

  • Team member
    T
    Daniel Weinbuch Business Development Manager @ Coriolis Pharma

  • Team member
    T
    Bettina von Klitzing-Stückle Scientific Marketing Manager @ Coriolis Pharma Research GmbH

Coriolis Pharma

Formulating Innovation

Coriolis Pharma is a globally operating contract research and development organization and one of the world leaders in formulation research and development of biopharmaceuticals including vaccines and ATMPs.